Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis

Molecular and Cellular Proteomics

Volumn 10, Issue 8, 2011, Pages

  Wright, C A ^a   Howles, S ^a,b   Trudgian, D C ^a   Kessler, B M ^a   Reynard, J M ^b   Noble, J G ^b   Hamdy, F C ^b   Turney, B W ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; STONE FORMATION; URINALYSIS; UROLITHIASIS;

ADULT; AGED; AGED, 80 AND OVER; AMIDOHYDROLASES; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CALCIUM OXALATE; CASE-CONTROL STUDIES; CERULOPLASMIN; CRYSTALLIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEINURIA; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; UROLITHIASIS; YOUNG ADULT;

EID: 80051644465     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.005686     Document Type: Article

References (51)

1. Stamatelou, K., Francis, M., Jones, C., Nyberg, L., and Curhan, G. (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 63, 1817-1823 (Pubitemid 36513328)
2. Miller, N., and Lingeman, J. (1968) Management of kidney stones. BMJ. 334, 468-472
3. Boyce, W. (1968) Organic matrix of human urinary concretions. Am. J. Med. 45, 673-683
4. Sugimoto, T., Funae, Y., Rübben, H., Nishio, S., Hautmann, R., and Lutzeyer, W. (1985) Resolution of proteins in the kidney stone matrix using high-performance liquid chromatography. Eur. Urol. 11, 334-340 (Pubitemid 16196188)
5. Ryall, R. (1993) The scientific basis of calcium oxalate urolithiasis. Predilection and precipitation, promotion and proscription. World J. Urol. 11, 59-65
6. Khan, S., and Kok, D. (2004) Modulators of urinary stone formation. Front Biosci. 9, 450-82
7. Grover, P., and Resnick, M. (1995) Evidence for the presence of abnormal proteins in the urine of recurrent stone formers. J. Urol. 153, 1716-1721
8. Cadieux, P., Beiko, D., Watterson, J., Burton, J., Howard, J., Knudsen, B., et al. (2004) Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis. J. Clin. Lab. Anal. 18, 170-175 (Pubitemid 38585794)
9. Ryall, R. (2004) Macromolecules and urolithiasis: parallels and paradoxes. Nephron. Physiol. 98, 37-42
10. Merchant, M., Cummins, T., Wilkey, D., Salyer, S., Powell, D., Klein, J., et al. (2008) Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am. J. Physiol. Renal. Physiol. 295, F1254-8
11. Ryall, R. (1997) Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J. Urol. 15, 155-164
12. Adachi, J., Kumar, C., Zhang, Y., Olsen, J., and Mann, M. (2006) The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 7, R80
13. Ginsberg, J., Chang, B., Matarese, R., and Garella, S. (1983) Use of single voided urine samples to estimate quantitative proteinuria. N. Engl. J. Med. 309, 1543-6 (Pubitemid 14212836)
14. Wessel, D., and Flügge, U. (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138, 141-3 (Pubitemid 14146660)
15. Xu, D., Suenaga, N., Edelmann, M., Fridman, R., Muschel, R., and Kessler, B. (2008) Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol. Cell Proteomics 7, 2215-2228
16. Kulaksizoglu, S., Sofikerim, M., and Cevik, C. (2007) Impact of various modifiers on calcium oxalate crystallization. Int. J. Urol. 14, 214-218 (Pubitemid 46423255)
17. Chutipongtanate, S., and Thongboonkerd, V. Red blood cell membrane fragments but not intact red blood cells promote calcium oxalate monohydrate crystal growth and aggregation. J. Urol. 184, 743-749
18. Tsujihata, M., Momohara, C., Yoshioka, I., Tsujimura, A., Nonomura, N., and Okuyama, A. (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J. Urol. 180, 2212-2217
19. Yoshioka, I., Tsujihata, M., Akanae, W., Nonomura, N., and Okuyama, A. (2011) Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys. Urology, 2011. 77, 1007.e9-1007.e14
20. Wai-Hoe, L., Wing-Seng, L., Ismail, Z., and Lay-Harn, G. (2009) Proteomics and detection of uromodulin in first-time renal calculi patients and recurrent renal calculi patients. Appl. Biochem. Biotechnol. 159, 221-232
21. Chen, D., Kaung, H., Miller, C., Resnick, M., and Marengo, S. (2004) Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int. 94, 637-650 (Pubitemid 39256497)
22. Mo, L., Liaw, L., Evan, A., Sommer, A., Lieske, J., and Wu, X. (2007) Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both. Am. J. Physiol. Renal Physiol. 293, F1935-43 (Pubitemid 350179618)
23. Kleinman, J., Wesson, J., and Hughes, J. (2004) Osteopontin and calcium stone formation. Nephron Physiol. 98, 43-47
24. Tardivel, S., Médétognon, J., Randoux, C., Kébédé, M., Drüeke, T., Daudon, M., et al. (1999) Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers. Urol. Res. 27, 243-249 (Pubitemid 29431739)
25. Okada, A., Yasui, T., Hamamoto, S., Hirose, M., Kubota, Y., Itoh, Y., et al. (2009) Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J. Bone Miner. Res. 24, 908-924
26. Das, L., and Brunner, H. (2009) Biomarkers for renal disease in childhood. Curr. Rheumatol. Rep. 11, 218-225
27. Kondo, C., Minowa, Y., Uehara, T., Okuno, Y., Nakatsu, N., Ono, A., et al. (2009) Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database. Toxicology 265, 15-26
28. Narita, T., Hosoba, M., Kakei, M., and Ito, S. (2006) Increased urinary excretions of immunoglobulin g, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes. Diabetes Care 29, 142-144 (Pubitemid 44033448)
29. Kim, C., Park, J., Kim, J., Choi, C., Kim, Y., Chung, Y., et al. (2002) Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: a population-based study. Metabolism 51, 838-842 (Pubitemid 34784807)
30. Asplin, J. (2009) Obesity and urolithiasis. Adv. Chronic Kidney Dis. 16, 11-20
31. Hennequin, C., Lalanne, V., Estepa, L., Drueke, T., Daudon, M., and Lacour, B. (1997) Validation by image analysis of a turbidimetric method to study calcium oxalate crystallization. Clin. Nephrol. 48, 292-299 (Pubitemid 27496653)
32. Boyce, C., Pickhardt, P., Lawrence, E., Kim, D., and Bruce, R. (2010) Prevalence of urolithiasis in asymptomatic adults: objective determination using low dose noncontrast computerized tomography. J. Urol. 183, 1017-1021
33. Akoudad, S., Szklo, M., McAdams, M., Fulop, T., Anderson, C., Coresh, J., et al. (2010) Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: The ARIC study. Prev. Med. 51, 416-420
34. Pearle, M., Calhoun, E., and Curhan, G. (2005) Urologic diseases in America project: urolithiasis. J. Urol. 173, 848-857 (Pubitemid 40239354)
35. Borghi, L., Meschi, T., Amato, F., Briganti, A., Novarini, A., and Giannini, A. (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J. Urol. 155, 839-843 (Pubitemid 26052660)
36. Taylor, E., Stampfer, M., and Curhan, G. (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293, 455-462
37. Taylor, E., Fung, T., and Curhan, G. (2009) DASH-style diet associates with reduced risk for kidney stones. J. Am. Soc. Nephrol. 20, 2253-2259
38. Ruggenenti, P., Gaspari, F., Perna, A., and Remuzzi, G. (1998) Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. BMJ 316, 504-509 (Pubitemid 28120955)
39. Schwille, P., Manoharan, M., and Schmiedl, A. (2005) Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study. Clin. Chem. Lab. Med. 43, 590-600 (Pubitemid 41460608)
40. Tannehill-Gregg, S., Dominick, M., Reisinger, A., Moehlenkamp, J., Waites, C., Stock, D., et al. (2009) Strain-related differences in urine composition of male rats of potential relevance to urolithiasis. Toxicol. Pathol. 37, 293-305
41. Canales, B., Anderson, L., Higgins, L., Slaton, J., Roberts, K., Liu, N., et al. (2008) Second prize: Comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix. J. Endourol. 22, 1161-1167 (Pubitemid 351913521)
42. Mushtaq, S., Siddiqui, A., Naqvi, Z., Rattani, A., Talati, J., Palmberg, C., et al. (2007) Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones. Clin. Chim. Acta. 384, 41-47 (Pubitemid 47247407)
43. Kaneko, K., Yamanobe, T., Nakagomi, K., Mawatari, K., Onoda, M., and Fujimori, S. (2004) Detection of protein Z in a renal calculus composed of calcium oxalate monohydrate with the use of liquid chromatography-mass spectrometry/mass spectrometry following two-dimensional polyacrylamide gel electrophoresis separation. Anal. Biochem. 324, 191-196 (Pubitemid 38019009)
44. Kaneko, K., Yamanobe, T., Onoda, M., Mawatari, K., Nakagomi, K., and Fujimori, S. (2005) Analysis of urinary calculi obtained from a patient with idiopathic hypouricemia using micro area x-ray diffractometry and LC-MS. Urol. Res. 33, 415-421 (Pubitemid 41778780)
45. Atmani, F., and Khan, S. (1999) Role of urinary bikunin in the inhibition of calcium oxalate crystallization. J. Am. Soc. Nephrol. 10 Suppl 14, S385-8 (Pubitemid 29498586)
46. Knörle, R., Schnierle, P., Koch, A., Buchholz, N., Hering, F., Seiler, H., et al. (1994) Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy. Clin. Chem. 40, 1739-1743 (Pubitemid 24273098)
47. Okada, A., Nomura, S., Higashibata, Y., Hirose, M., Gao, B., Yoshimura, M., et al. (2007) Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol. Res. 35, 89-99 (Pubitemid 46723564)
48. Bento, I., Peixoto, C., Zaitsev, V., and Lindley, P. (2007) Ceruloplasmin revisited: structural and functional roles of various metal cation-binding sites. Acta Crystallogr. D 63, 240-248 (Pubitemid 46197541)
49. Bilobrov, V., Bogdan, N., Bilobrov, S., and Roy, A. (2002) Influence of cations and total protein of urine on the solubility and probability of urate stone formation in kidneys. Urol. Int. 68, 118-121 (Pubitemid 34136868)
50. Atakan, I., Kaplan, M., Seren, G., Aktoz, T., Gül, H., and Inci, O. (2007) Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients. Int. Urol. Nephrol. 39, 351-356 (Pubitemid 47054822)
51. di Patti, M., Maio, N., Rizzo, G., De Francesco, G., Persichini, T., Colasanti, M., et al. (2009) Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia. J. Bio. Chem. 284, 4545-4554